Molina Healthcare (NYSE:MOH – Get Free Report) had its target price decreased by investment analysts at Barclays from $372.00 to $339.00 in a report issued on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 19.40% from the stock’s current price.
A number of other research analysts also recently commented on MOH. Cantor Fitzgerald reissued an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, October 24th. UBS Group cut their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research report on Friday. StockNews.com raised shares of Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 31st. Truist Financial cut their price objective on shares of Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Wells Fargo & Company lifted their price objective on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, four have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Molina Healthcare has an average rating of “Moderate Buy” and a consensus target price of $355.67.
Check Out Our Latest Analysis on MOH
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. As a group, research analysts expect that Molina Healthcare will post 23.44 EPS for the current fiscal year.
Hedge Funds Weigh In On Molina Healthcare
Several large investors have recently made changes to their positions in the company. Marshall Wace LLP purchased a new stake in Molina Healthcare in the 2nd quarter worth $416,000. Algert Global LLC purchased a new stake in shares of Molina Healthcare in the second quarter valued at about $211,000. Sanctuary Advisors LLC purchased a new stake in shares of Molina Healthcare in the second quarter valued at about $1,077,000. Czech National Bank grew its holdings in shares of Molina Healthcare by 6.9% in the third quarter. Czech National Bank now owns 11,937 shares of the company’s stock valued at $4,113,000 after purchasing an additional 771 shares during the period. Finally, GAMMA Investing LLC lifted its position in Molina Healthcare by 59.2% in the third quarter. GAMMA Investing LLC now owns 543 shares of the company’s stock valued at $187,000 after buying an additional 202 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
- Five stocks we like better than Molina Healthcare
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- How to trade using analyst ratings
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Comparing and Trading High PE Ratio Stocks
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.